CME

Optimal Use of Biologics and Biosimilars in IBD: What, When, and in Whom?

Optimal Use of Biologics and Biosimilars in IBD: What, When, and in Whom?

This activity is supported by an educational grant from Merck & Co., Inc.

Overview

CME Information

page 1 of 8